Navigation Links
Commercial Insight: Antihormonal Cancer Therapies - Leading Brands Strive to Minimize Generic Sales Erosion
Date:11/8/2010

antihormonal therapy drug classes in the seven major pharmaceutical markets ($m), 2009-2019 10

Table 3: Key events impacting the antihormonal therapies market in the seven major markets, 2009-2019 11

Table 4: Antihormonal therapy sales forecasts in the seven major markets ($m), 2009-2019 16

Table 5: Summary of opportunities and threats that will impact the antihormonals market across the seven major markets, 2009-2019 17

Table 6: Sales and growth of antihormonal therapy drug classes in the US ($m), 2009-2019 21

Table 7: Top 5 branded antihormonals in the US in 2009 and 2019 23

Table 8: Antihormonal therapy sales forecasts in the US ($m), 2009-2019 24

Table 9: Summary of opportunities and threats to impact the antihormonals market in the US, 2009-2019 25

Table 10: Sales and growth of antihormonal therapy drug classes in Japan ($m), 2009-2019 28

Table 11: Top 5 branded antihormonals in Japan in 2009 and 2019 30

Table 12: Antihormonal therapy sales forecasts in Japan ($m), 2009-2019 31

Table 13: Summary of opportunities and threats to impact the antihormonals market in Japan, 2009-2019 32

Table 14: Sales and growth of antihormonal therapy drug classes in the five major EU markets ($m), 2009-2019 36

Table 15: Top 5 branded antihormonals in the five major EU markets in 2009 and 2019 38

Table 16: Antihormonal therapy sales forecasts in the five major EU markets ($m), 2009-2019 39

Table 17: Summary of opportunities and threats to impact the antihormonals market in the five major EU markets, 2009-2019 40

Table 18: Risk-sharing agreements between NICE and selected pharma companies in the UK, 2009-2010 46

Table 19: Sales and growth of antihormonal therapy drug classes in France ($m), 2009-2019 48

Table 20: Top 5 branded antihormonals in France in 2009 and 2019 49

Table 21: Antihormonal therapy sales forecasts in France ($m), 2009-2019 50


'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs
2. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
3. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
4. High Unemployment Rates in North Carolina Will Continue to Dictate the Decrease of Commercial Health Plan Enrollment and the Increase of Medicaid Enrollment
5. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
6. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
7. Biocon and Pfizer Enter Into Global Commercialization Agreement
8. TaiGen Amends Global License Agreement with Warner Chilcott plc for Development and Commercialization of Nemonoxacin -- a New Generation Quinolone Antibiotic
9. OLIGOMERIX, Inc. Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer
10. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
11. Concentric Medical Announces Commercial Launch of Trevo™ in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... ) has announced the addition of the ... report to their offering.      ... have been broadly classified into wide categories ... used for the treatment of different gynecological ...
(Date:9/19/2014)... DALLAS , September 19, 2014 ... Equipment Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), ... End Users (Hospitals), Advanced technologies - Global Forecast ... Market is poised to reach $19,786.3 Million by ... CAGR of 6.8% from 2014 to 2019. ...
(Date:9/19/2014)... -- Research and Markets has announced the addition ... Diarrhea, Mental Disorder) Market - Forecast to 2023" report ... report, the human microbiome market is segmented by application, disease, ... expected to be valued as $294 million in 2019 and ... the forecast period of 2019-2023. The market is driven by ...
Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 3
... September 26, 2011 EJC App Now Available on ... scientific, technical and medical information products and services, today announced the ... Cancer ( EJC ). Starting with the September 2011 issue, ... available through the EJC App on the App Store. iPad editions ...
... PARSIPPANY, N.J., Sept. 26, 2011 Pacira ... today announced that the company,s lead investigational product ... injectable suspension), was highlighted in the "Hot Topics ... assembly of the American Society of Plastic Surgeons ...
Cached Medicine Technology:Elsevier Launches European Journal of Cancer iPad Edition 2Elsevier Launches European Journal of Cancer iPad Edition 3Pacira Pharmaceuticals, Inc. Announces Efficacy and Safety of EXPAREL™ Highlighted at "Hot Topics in Plastic Surgery" Panel at the 2011 Annual Meeting of the American Society of Plastic Surgeons 2Pacira Pharmaceuticals, Inc. Announces Efficacy and Safety of EXPAREL™ Highlighted at "Hot Topics in Plastic Surgery" Panel at the 2011 Annual Meeting of the American Society of Plastic Surgeons 3Pacira Pharmaceuticals, Inc. Announces Efficacy and Safety of EXPAREL™ Highlighted at "Hot Topics in Plastic Surgery" Panel at the 2011 Annual Meeting of the American Society of Plastic Surgeons 4Pacira Pharmaceuticals, Inc. Announces Efficacy and Safety of EXPAREL™ Highlighted at "Hot Topics in Plastic Surgery" Panel at the 2011 Annual Meeting of the American Society of Plastic Surgeons 5
(Date:9/20/2014)... September 20, 2014 Ticket Down ... tickets . This popular ticket exchange is offering their ... , The 2015 schedule of tours is beginning to fill ... announced their plans to hit the road, including 21-year-old pop ... announced the “Honeymoon Tour,” which will take her to 25 ...
(Date:9/20/2014)... 20, 2014 Lifeinsurancequoteterm.net has released ... no medical exam life insurance plan provides for vulnerable ... family members should be a top priority for every ... insurance without taking medical examinations and visiting a doctor. ... medical examinations will provide coverage up to $300,000, but ...
(Date:9/20/2014)... 2014 New PharmaPoint Drug Evaluation ... to 2023?. The asthma market saw very slow ... become saturated with relatively efficacious standard therapies, such ... corticosteroids and long-acting beta-agonists (ICS/LABAs), and leukotriene modifiers, ... However, the launch of seven novel targeted biologic ...
(Date:9/20/2014)... September 20, 2014 Traditionally dentists have advised ... South Charlotte Dentistry is re-visiting that advice and ... effects that coffee and wine have on oral health. “There’s ... determined that coffee may be beneficial in protecting against gum ... , The study on coffee was from the September ...
(Date:9/20/2014)... September 20, 2014 QueenBeeTickets.com is ready ... star’s tour performances. She will visit many cities in ... until the 16th of April. , Click Here ... Tour tickets at QueenBeeTickets.com. , The star’s fans are ... see their favorite young singer in a live performance. ...
Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2
... Japan, May 8 Dr. Hidenari Tanaka, president ... of the Japan Contact Lens Association, was appointed ... the government of the Republic of Singapore. The ... Consulate-General will be located at Menicon,s corporate headquarters ...
... HealthSystem Consortium (UHC) today announced that it has awarded ... in Gaithersburg, Md, for food and nutrition services. The ... effective on May 1, 2009. Sodexo is a leading ... services to hospital patients, staff, and visitors. Services are ...
... Reform Work for ChildrenSTANFORD, Calif., May 7 Lucile ... the National Association of Children,s Hospitals (N.A.C.H.) as it ... Congress and the Obama Administration to make health care ... extraordinarily proud to be taking part in Speak Now ...
... Inc., (Nasdaq: MEDQ ) a leading provider of ... workflow, today announced its unaudited operating results for its first ... of 2009 was $6.9 million, an increase of $11.3 million ... $4.4 million was reported. Earnings per share for the first ...
... Va., May 7 Trey Anastasio, lead singer of the ... Hill on Wednesday, May 6, to participate in a day-long ... joined the National Association of Drug Court Professionals (NADCP) in ... in need. Mr. Anastasio recognized over fifteen members of Congress ...
... is a statement from Georges C. Benjamin, MD, FACP, ... Association:"The American Public Health Association (APHA) joins other leading ... in President Obama,s FY 2010 budget."Of particular note is ... be used to finance health reform and ensure that ...
Cached Medicine News:Health News:Dr. Tanaka Appointed as Honorary Consul-General by Republic of Singapore 2Health News:University HealthSystem Consortium Selects Sodexo to Provide Food and Nutrition Services 2Health News:Lucile Packard Children's Hospital at Stanford to Raise Its Voice for Kids in Health Care Reform Debate 2Health News:Lucile Packard Children's Hospital at Stanford to Raise Its Voice for Kids in Health Care Reform Debate 3Health News:MedQuist Reports First Quarter 2009 Results 2Health News:MedQuist Reports First Quarter 2009 Results 3Health News:MedQuist Reports First Quarter 2009 Results 4Health News:MedQuist Reports First Quarter 2009 Results 5Health News:MedQuist Reports First Quarter 2009 Results 6Health News:MedQuist Reports First Quarter 2009 Results 7Health News:MedQuist Reports First Quarter 2009 Results 8Health News:MedQuist Reports First Quarter 2009 Results 9Health News:Phish Frontman Trey Anastasio Visits Capitol Hill to Support Drug Courts and Calls on Congress to Put a Drug Court Within Reach of Every American in Need 2Health News:Phish Frontman Trey Anastasio Visits Capitol Hill to Support Drug Courts and Calls on Congress to Put a Drug Court Within Reach of Every American in Need 3Health News:APHA Applauds Health Reform Fund and Other Health Investments in Budget 2
Serrated handle with 7 mm tying platform and polished finish. Teeth: 0.25 mm, 2 x 2 set at 45 degrees....
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 90 degrees....
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 45 degrees....
6 mm tying platform. Round knurled handle with polished finish. Teeth: 0.3 mm, 1 x 2. Orientation: Left hand....
Medicine Products: